Drug Information

Drug General Information
Drug ID
D05HGL
Former ID
DIB001912
Drug Name
GW-695634
Synonyms
GW-5634; GW-5634 Na salt; GW-5634 sodium salt; GW-678248; GW-8248; GW-8635; Non-nucleoside reverse transcriptase inhibitor (hiv infection), GlaxoSmithKline; 678248; 695634
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Phase 1 [521608]
Company
GlaxoSmithKline plc
Structure
Download
2D MOL

3D MOL
Canonical SMILES
S(=O)(=O)(c1cc(c(NC(=O)COc2c(C(=O)c3cc(C#N)cc(c3)Cl)cc(<br />cc2)Cl)cc1)C)N
Target and Pathway
Target(s) HIV reverse transcriptase Target Info Inhibitor [528050]
References
Ref 521608ClinicalTrials.gov (NCT00090077) Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected Adults. U.S. National Institutes of Health.
Ref 528050Next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors. Curr Opin Investig Drugs. 2006 Feb;7(2):128-35.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.